Trial · NCT02736305
Use of Regorafenib in Recurrent Epithelial Ovarian Cancer
NCT02736305, Phase 2, Completed, National Cancer Centre, Singapore
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Use of Regorafenib in Recurrent Epithelial Ovarian Cancer. Trials, record NCT02736305. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02736305
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Use of Regorafenib in Recurrent Epithelial Ovarian Cancer
- NCT number
- NCT02736305
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 21 participants, actual
- Lead sponsor
- National Cancer Centre, Singapore
- Conditions
- Ovarian Neoplasms
- Interventions
- Regorafenib
- First posted
- 2016-04-13
- Last updated
- 2022-06-13
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Investigator assessed progression free survival (PFS) | 30 days after the last dose of regorafenib | |
| Secondary | Overall survival (OS) | 30 days after the last dose of regorafenib | |
| Secondary | Overall tumour response rate (ORR) as per Gynecological Cancer Intergroup (GCIG) and RECIST v1.1 criteria | 30 days after the last dose of regorafenib | |
| Secondary | Treatment Emergent Adverse Events | 30 days after the last dose of regorafenib | During the study period, patients will undergo evaluations for safety and drug tolerability. * Unexpected and expected toxicities including Hand Foot Syndrome, Liver dysfunction, Hypertension, Bleeding, Nausea and Diarrhoea * Death |
| Other | Health Related Quality of Life (HRQoL) | 30 days after the last dose of regorafenib | |
| Other | Maximum Plasma Concentration [Cmax] | 30 days after the last dose of regorafenib | |
| Other | Area Under the Curve (AUC) | 30 days after the last dose of regorafenib |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02736305
GET https://conductscience.org/api/trials/v1/NCT02736305/registered